[The influence of antiseptic solutions used against AIDS on dental waxes, shellac bases, impression compound and zinc-oxide eugenol paste] NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The influence of antiseptic solutions used against AIDS on dental waxes, shellac bases, impression compound and zinc-oxide eugenol paste]

Hell Stomatol Chron. 1989 Jul-Sep;33(3):149-57. Unique Identifier : AIDSLINE MED/91079020
Kotsiomiti H; Totsika A; Diakoyianni-Mordohai H; Kaloyiannides A

Abstract: The influence of four antiseptic solutions on some dental materials was examined in this study. The antiseptic solutions were sodium chloride 10%, alcohol 75%, Cidex and Sterile pack fluid, whereas the dental materials were dental modelling wax, impression compound, shellac base plate and zinc-oxide eugenol paste. The change of weight and the change of length which were observed in 40 minutes were measured. According to our results the modelling waxes, as well as the impression paste are not influenced by the antiseptic solutions. The impression compound must not be sterilised in Sterile pack fluid, which dissolves it, but it can be floated in the rest of the solutions. The shellac base plates are influenced by all the antiseptic solutions studied, especially by alcohol 75% and Sterile pack fluid.
Keywords: Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL Comparative Study *Dental Impression Materials *Disinfectants English Abstract *Resins *Waxes *Zinc Oxide-Eugenol Cement JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/prevention&controlcomparativestudyKWDdentalimpressionmaterialsKWDdisinfectantsenglishabstractKWDresinsKWDwaxesKWDzincoxide-eugenolcementjournalarticle
910430
M9140677

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .